Levothyroxine Sodium Tablet — FDA Drug Shortage
The FDA lists a drug shortage record for Levothyroxine Sodium Tablet (tablet) from EMD Serono, Inc. with status No longer listed by FDA. The shortage was first posted on Jul 10, 2025.
Shortage details
- Status
- No longer listed by FDA
- Company
- EMD Serono, Inc.
- Package NDC
- 72305-075-90
- Dosage Form
- Tablet
- Presentation
- Euthyrox, Tablet, 75 ug (NDC 72305-075-90)
- Initial Posting
- Jul 10, 2025